Central Nervous System Disease Drives Mortality in HER2+ Metastatic Breast Cancer Despite Longer Survival
Patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC) with central nervous system (CNS) disease had longer overall survival (OS) and decreased mortality risk compared with those who have extracranial metastasis, according to study results published in JAMA Network Open. The findings suggest that aggressive local and systemic therapies may be … Read more